Our previous study showed that a small molecule, specific aurora A kinase inhibitor, MK-5108, decreases neuroblastoma cell survival, and when used in combination with the 14G2a mAb, significantly potentiates cytotoxicity against neuroblastoma cells in vitro, as compared to MK-5108 used alone [11]. The gene discussed is AURKA; the disease is neuroblastoma.